Owner Scorecard


← All companies ← IDT Manual IDYA → ← IBRX Biotechnology IMCR →

IDXX, IDEXX Laboratories Inc.

Biotechnology consumer brand

Revenue is Products (59%) and Services (41%).

Latest annual: FY2025 10-K
IDXX · IDEXX Laboratories Inc.
I

The business

What it sells, where the money comes from, the kind of company it is.

Revenue · FY2025
$4.3B
+10.4% YoY · 10% 5-yr CAGR
Vital signs · TTM, with 5-yr average
Revenue $4.4B 5-yr avg $3.7B
Gross margin 62% 5-yr avg 60%
Operating margin 31.6% 5-yr avg 29.2%
ROIC 50% 5-yr avg 53%
Owner-earnings margin 24% 5-yr avg 20%
Free cash flow margin 24% 5-yr avg 20%

The business in brief

read the 10-K →

What this business is and what moves its needle, from its own SEC filings.

What it is
A pharmaceutical business, where patents grant a temporary monopoly the pipeline must keep refilling.
What moves the needle
Gross margin has run about 58% and operating margin about 26% through the cycle, a wide spread between price and the cost of what it sells — whether that advantage is durable pricing power or a margin that can erode is the question the record is for. Read this kind of business on the pipeline against the patent cliff, and pricing. On its own account, the filing leans hardest on customer concentration, set against the numbers in what the filing emphasizes, below.
Is it a good business?
Return on capital has run high across the record (median 57%, above 15% in 10 of 10 years), though buybacks and expensed R&D and brands shrink the capital base, so the figure overstates the underlying economics. The steadier read is owner earnings: roughly 18% of revenue reaches owners as cash, consistently. Whether these returns reflect real pricing power or an accounting artifact is the judgment the 10-K is for.

Every line is arithmetic on the company's filings, shown in full in the sections below.

Where the money comes from

read the 10-K →

Revenue spreads across 2 lines, the largest Products at 59%.

Revenue by product line, FY2025
  • Products59%$2.5B
  • Services41%$1.8B

From the segment footnote of the company's own 10-K. Shares are of total revenue; the profit bar shows each segment's share of segment operating profit, before unallocated corporate costs.

II

The record

Ten years of arithmetic, read across the cycle.

The record, 2016–2025

realized figures from each filing · older years to the left
2016’162017’172018’182019’192020’202021’212022’222023’232024’242025’25TTMTTMMar 2026
Income statement
$1.8B$2.0B$2.2B$2.4B$2.7B$3.2B$3.4B$3.7B$3.9B$4.3B$4.4BRevenueRevenue
55%56%56%57%58%59%60%60%61%62%62%Gross marginGross mgn
12%11%11%11%11%10%10%9%11%9%10%SG&A / revenueSG&A/rev
6%6%5%6%5%5%8%5%6%6%6%R&D / revenueR&D/rev
$350M$413M$491M$553M$695M$932M$899M$1.1B$1.1B$1.4B$1.4BOperating incomeOp. inc.
19.7%21.0%22.2%23.0%25.7%29.0%26.7%30.0%29.0%31.6%31.6%Operating marginOp. mgn
$222M$263M$377M$428M$582M$745M$679M$845M$888M$1.1B$1.1BNet incomeNet inc.
31%31%18%18%12%17%21%20%20%20%20%Effective tax rateTax rate
Cash flow & returns
$339M$373M$400M$459M$648M$756M$543M$907M$929M$1.2B$1.2BOperating cash flowOp. cash
$78M$83M$83M$88M$96M$105M$112M$115M$130M$145M$149MDepreciationDeprec.
$19M$3M($85M)($96M)($61M)($132M)($298M)($113M)($149M)($83M)($96M)Working capital & otherWC & other
$65M$74M$116M$155M$107M$120M$149M$134M$121M$125M$127MCapexCapex
3.6%3.8%5.2%6.4%4.0%3.7%4.4%3.7%3.1%2.9%2.8%Capex / revenueCapex/rev
$274M$299M$317M$371M$541M$636M$431M$773M$808M$1.1B$1.1BOwner earningsOwner earn.
15.4%15.2%14.3%15.4%20.0%19.8%12.8%21.1%20.7%24.6%24.4%Owner earnings marginOE mgn
$274M$299M$284M$304M$541M$636M$394M$773M$808M$1.1B$1.1BFree cash flowFCF
15.4%15.2%12.8%12.6%20.0%19.8%11.7%21.1%20.7%24.6%24.4%Free cash flow marginFCF mgn
$2M$15M$23M$50M$2M$173M$12M$0$77M$0$0AcquisitionsAcquis.
$304M$283M$369M$302M$183M$747M$820M$72M$837M$1.2BBuybacksBuybacks
73%78%86%58%53%55%56%51%47%58%50%ROICROIC
241%92%108%112%57%56%66%70%Return on equityROE
241%92%108%112%57%56%66%70%Retained to equityRetained/eq
Balance sheet
$155M$188M$124M$90M$384M$144M$113M$454M$288M$180M$201MCash & investmentsCash+inv
$204M$235M$249M$269M$331M$368M$401M$457M$474M$552M$604MReceivablesReceiv.
$158M$164M$173M$195M$210M$269M$368M$380M$382M$378M$382MInventoryInvent.
$60M$67M$70M$72M$75M$116M$110M$111M$114M$110M$130MAccounts payablePayables
$302M$332M$353M$392M$467M$521M$658M$727M$741M$820M$856MOperating working capitalOper. WC
$846M$972M$654M$680M$1.1B$956M$1.1B$1.5B$1.4B$1.4B$1.5BCurrent assetsCur. assets
$935M$1.0B$770M$725M$583M$764M$1.2B$952M$1.1B$1.1B$1.3BCurrent liabilitiesCur. liab.
0.9×1.0×0.8×0.9×1.8×1.3×0.9×1.6×1.3×1.2×1.1×Current ratioCurr. ratio
$178M$200M$214M$240M$243M$359M$362M$366M$405M$414M$412MGoodwillGoodwill
$1.5B$1.7B$1.5B$1.8B$2.3B$2.4B$2.7B$3.3B$3.3B$3.4B$3.4BTotal assetsAssets
$594M$607M$602M$699M$908M$850M$769M$698M$618M$450M$900MTotal debtDebt
$439M$419M$478M$609M$525M$706M$657M$244M$329M$270M$699MNet debt / (cash)Net debt
10.9×11.1×14.1×17.8×21.0×31.3×22.5×26.4×36.2×35.0×36.1×Interest coverageInt. cov.
($108M)($54M)($10M)$177M$632M$690M$609M$1.5B$1.6B$1.6B$1.6BShareholders’ equityEquity
1.1%1.2%1.1%1.6%1.1%1.2%1.5%1.6%1.5%1.4%1.4%Stock comp / revenueSBC/rev
Per share
90.9M89.6M88.5M87.5M86.7M86.6M84.6M84.0M83.2M81.0M80.2MShares out (diluted)Shares
$19.54$21.98$25.02$27.49$31.21$37.14$39.80$43.59$46.82$53.12$55.46Revenue / shareRev/sh
$2.44$2.94$4.26$4.89$6.71$8.60$8.03$10.06$10.67$13.08$13.66EPS (diluted)EPS
$3.02$3.34$3.58$4.24$6.24$7.35$5.10$9.20$9.71$13.05$13.52Owner earnings / shareOE/sh
$3.02$3.34$3.21$3.47$6.24$7.35$4.66$9.20$9.71$13.05$13.52Free cash flow / shareFCF/sh
$0.71$0.83$1.31$1.77$1.23$1.38$1.76$1.59$1.45$1.54$1.58Cap. spending / shareCapex/sh
$-1.19$-0.60$-0.11$2.03$7.29$7.97$7.20$17.68$19.16$19.81$19.41Book value / shareBVPS
Per-share growththe realized rate an owner's share compounded
9-yr5-yr
Revenue / share+11.8%/yr+11.2%/yr
Owner earnings / share+17.7%/yr+15.9%/yr
EPS+20.5%/yr+14.3%/yr
Capital spending / share+8.9%/yr+4.5%/yr
Book value / share+22.1%/yr

The record, charted

FY2016–2025

Each measure over its full record; the current point and the worst year marked.

Share count
81Mpeak FY2016
ROIC
58%low FY2024
Gross margin
62%low FY2016
Net debt ÷ owner earnings
0.3×peak FY2019

Owner earnings vs. net income

Owner earningsNet income

The accountant's number, and the cash an owner can take; the gap is the tell.

$1.1Bowner earningsvs.$1.1Bnet incomelow FY2016

Where the cash went

ReinvestBuybacksDividendsAcquisitionsRetainedBeyond op. cash

Each year's outlays against its operating cash: the mix, and how it drifts. The hatched cap is spending beyond that year's operating cash — financed from the balance sheet or borrowing, not operations.

FY2016FY2025

Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.

In fiscal 2025 the business reported $1.1B of profit but $1.1B of owner earnings: $2M less than the profit line, taken out by capital spending and the timing of cash.

Reported net income$1.1B
Owner earnings$1.1B · 25% of revenue
FY2025FY2024FY2023FY2022FY2021
Reported net income$1.1B$888M$845M$679M$745M
Depreciation & amortizationnon-cash charge added back+$145M+$130M+$115M+$112M+$105M
Stock-based compensationreal costnon-cash, but a real cost+$60M+$60M+$60M+$50M+$38M
Working capital & othertiming of cash in and out, other non-cash items−$83M−$149M−$113M−$298M−$132M
Cash from operations$1.2B$929M$907M$543M$756M
Maintenance capital expenditurethe spending needed just to hold position and volume−$125M−$121M−$134M−$112M−$120M
Owner earnings$1.1B$808M$773M$431M$636M
Growth capital expenditurediscretionary; spent to get bigger, not to stand still−$37M
Free cash flow$1.1B$808M$773M$394M$636M
Owner-earnings marginowner earnings ÷ revenue25%21%21%13%20%

Owner earnings is the cash an owner could pull out without starving the business: operating cash less the capital it must spend to hold its position . The cash-flow statement also adds stock comp back as non-cash, but it is a real cost paid in shares; counted as the expense it is (less $60M), owner earnings is nearer $997M.

Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.

III

Quality & stewardship

Returns, the balance sheet, capital allocation, and pay.

Owner’s Scorecard

FY2025 10-K · source on SEC EDGAR →

Will it survive?

  • Comfortable
    Operating income $1.4B ÷ interest expense $39M
    What this means

    Operating profit covers interest with the kind of margin Graham wanted for a defensive holding. Necessary, not sufficient, it says solvent, not cheap.

  • How heavy is the debt, net of cash? $519M · 0.4× operating profit
    Modest net debt
    Cash $180M − debt $699M
    What this means

    Netting $180M of cash and short-term investments against $699M of debt leaves $519M owed, about 0.4× a year's operating profit (0.5× on the gross debt, before the cash). Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.

  • Long (60+ days)
    DSO 47 + DIO 84 − DPO 25 days
    What this means

    Days cash is tied up between paying suppliers and collecting from customers. Lower is better; a long cycle means growth itself eats cash.

Is it a good business?

  • Very high (≥25%) through the cycle
    10-yr median, range 47%–86%; 51% latest = NOPAT $1.1B ÷ invested capital $2.1B
    Industry peers: median -1%
    What this means

    The rate the business earns on the money tied up in it, Buffett's north star, because over time a stock tracks the ROIC beneath it. Above ~15% sustained hints at a moat; a return below the cost of capital (~8%) erodes value as a business grows rather than building it — the test Buffett weighs most. The headline is the median of the last 10 years (it ran 51% most recently), so one peak or trough year doesn't set the verdict. Asset-light businesses (R&D expensed, little capital) read artificially high, pair this with Owner Earnings.

  • High through the cycle
    10-yr median margin, range 13%–25%; latest $1.1B = operating cash $1.2B − maintenance capex $125M
    Industry peers: median 2%
    What this means

    What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's 25% of revenue this year, a 15% median across 10 years. Treating stock comp as the real expense it is (less $60M of SBC) leaves $997M.

  • Cash-backed
    Cash from ops $1.2B ÷ net income $1.1B
    What this means

    How much of reported profit showed up as operating cash. Above 1× is reassuring; well below suggests earnings lean on accruals. One year is noisy, growth and working-capital swings distort it, and this is operating cash, not free cash. Watch the multi-year trend.

How is the cash used?

  • Returned more than it generated
    Dividends + buybacks $1.2B ÷ Owner Earnings $1.1B
    What this means

    The company returned more than it generated: against $1.1B of Owner Earnings, $1.2B (115%) went back to shareholders, $0 dividends, $1.2B buybacks — the excess came from the balance sheet or borrowing, not the year's operations. Net of $60M stock comp, the real buyback was about $1.2B. Sustained, that pattern draws down cash or adds debt; the net-debt line above shows where it stands.

  • Investing or harvesting? 0.86×
    Maintaining
    Capex $125M ÷ depreciation $145M
    What this means

    Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.

Graham’s defensive tests · 3 of 6 met

Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.

  • Adequate size Pass
    Revenue ≥ $2B · $4.3B
    What this means

    Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.

  • Strong liquidity Miss
    Current ratio ≥ 2× · 1.23×
    What this means

    Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.

  • Conservative debt Miss
    Debt ≤ working capital · $699M vs $265M WC
    What this means

    Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.

  • Earnings stability Pass
    A profit every year (10-yr record) · no losses
    What this means

    Graham wanted earnings in each of the past ten years, the stability a defensive owner leans on.

  • Dividend record Miss
    Uninterrupted dividends · none paid
    What this means

    An unbroken dividend was Graham's mark of durability. He wanted twenty years; the filings show about ten, and a single suspension breaks the streak. Non-payers, many fine modern compounders, fall outside his defensive net by design.

  • Earnings growth Pass
    Earnings +33% over the record · +224%
    What this means

    At least a third more earnings than a decade ago, averaging three years at each end. Net income (not per-share), so stock splits don't distort it, buybacks and dilution show up in the share-count line instead.

  • Moderate price
    P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
    What this means

    Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $11.80/share (latest year $13.43), the averaged base the calculator's gate runs on, and book value is $20.35/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.

Durability & moat, 2016–2025

Whether the record’s returns held, and what the capital reinvested earned.

  • Profitable years 10 of 10
    What this means

    Never lost money over the record, the earnings stability Graham insisted on.

  • Return on capital ≥ 15% 10 of 10 yrs
    What this means

    A moat shows up as a high return on invested capital that holds year after year, not one good vintage.

  • Operating margin 21% → 30% (3-yr avg ends)

    In the filing’s words The words confirm the number: the filing says price increases held their volume, and the margin widened with them — Buffett’s strongest mark of pricing power.

    What this means

    Through the cycle the operating margin widened — about 21% early to 30% lately, median 26% — pricing power intact or improving.

  • Reinvestment, incremental ROIC 44%
    What this means

    Every extra dollar the business reinvested came back at a high incremental return — the lens GBM read for a moat that reinvests rather than merely harvests. The record and the 10-K are where you check whether the rate holds.

  • Owner earnings growth +14%/yr
    What this means

    Owner earnings grew about 14% a year over the record.

  • Worst year 2016 · 19.7% op. margin
    What this means

    Stayed profitable even in its hardest year, the resilience that survives recessions.

  • Share count −1.3%/yr
    What this means

    The share count is shrinking, buybacks are quietly growing your slice of the business.

Does AI threaten the moat?

Low contestability

The moat is physical, regulated or balance-sheet-funded, the kind AI cuts costs within but does not contest.

AI is unlikely to contest a moat that is physical, regulated or balance-sheet-funded; here it reads more as a cost tool than a threat.

Read from the filing's own risk factors, paired with the industry's structure under its SIC code; the durability is read above, the price below.

All figures as filed; the source filing is linked above.

Current Position

as of the latest quarter, Mar 31, 2026

Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.

Current assets$1.5B
  • Cash & short-term investments$201M
  • Receivables$604M
  • Inventory$382M
  • Other current assets$268M
Current liabilities$1.3B
  • Debt due within a year$150M
  • Accounts payable$130M
  • Other current liabilities$1.0B
Current ratio1.12×all current assets ÷ what's due · Graham looked for 2×
Quick ratio0.82×stricter: inventory excluded
Cash ratio0.15×strictest: cash alone against what's due
Working capital$154Mthe cushion left after near-term bills
Debt due this year vs. cash$150M due · $201M cash covered by cash on hand, no refinancing forced · both figures from the Mar 31, 2026 balance sheet
Revenue, latest quarter vs. a year ago+14.3%the freshest read on whether the business is still growing
Current ratio, recent quarters1.4× → 1.1×
Deeper floors
Tangible book value$1.0Bequity stripped of goodwill & intangibles
Net current asset value($375M)Graham's net-net: current assets less all liabilities
Debt incl. operating leases$575M$126M of it operating leases
Deferred revenue$69Mcustomer cash collected before delivery; operating float

From the company's latest filing.

How the cash was used, 2016–2025

Over the record, the business generated $6.5B of operating cash; how management split it reads as a cash returner, paying most of what it earns straight back to owners.

  • Reinvested$1.2B · 18%
  • Buybacks$5.1B · 79%
  • Retained (debt / cash)$238M · 4%
  • Returned to owners$5.1B

    93% of the owner earnings the business produced over the span, $0 as dividends and $5.1B as buybacks.

  • Average price paid for buybacks$311.97

    Across the years where the filing reports a share count, 16M shares were bought for $5.1B, about $311.97 each. Year to year the price paid ranged from $97.12 (2016) to $569.19 (2021); its heaviest year, 2025, paid $501.43 ($1.2B).

  • Net change in share count−11.8%

    The diluted count fell from 91M to 80M, so the buybacks outran the stock issued to staff.

  • Dividend record

    No dividend line was reported in the filing data over the span; the record here neither confirms nor rules out a payout.

  • Return on what it retained61%

    Of the earnings it kept rather than paid out ($955M over the span), annual owner earnings (first three years vs last three) grew $583M, so each retained $1 added about 0.61 of yearly owner earnings. Buffett's test, run on owner earnings instead of market value.

Buybacks are gross of stock issued to staff; the share-count line above is the net of that, the figure that decides whether owners gained. The average price paid blends a year of purchases (and any accelerated repurchase), so it is close, not exact. The record of where the cash went and on what terms.

Management, ownership & pay

read the proxy →

From the proxy: how much of the business the people running it own, and how they are paid, beside what the business earned for its owners in the same years.

Fiscal yearChief executivePay, as filed“Actually paid”Owner earnings
2021Jonathan J. Mazelsky$9.1M$28.2M$636M
2022Jonathan J. Mazelsky$9.8M−$13.8M$431M
2023Jonathan J. Mazelsky$11.5M$22.7M$773M
2024Jonathan J. Mazelsky$13.0M$2.3M$808M
2025Jonathan J. Mazelsky$14.6M$31.8M$1.1B

Both pay figures are the company’s own, from the pay-versus-performance table its proxy statement files. “As filed” is the Summary Compensation Table total: salary, bonus, and equity awards at their value on the day of grant. “Actually paid” is the SEC’s prescribed recalculation, which re-marks those equity awards to what they became as they vested; it can swing far above or below the filed figure in either direction, and negative years occur. Owner earnings are the whole business's, from the record above, for the same fiscal years.

  • Insider ownership0.8%

    The stake all directors and executive officers hold together, per the 2026 proxy: skin in the game, the first thing Munger reads.

  • Stock-based compensation$60M

    The slice of the business handed to employees in shares this year, 1% of revenue, equal to 4% of operating profit. Buffett's oldest accounting fight: this is compensation, compensation is an expense, real whether or not the headline earnings admit it. One trap: the cash-flow statement adds SBC back, so the operating cash, and the owner earnings drawn from it, are flattered by exactly this amount; counted as the cost it is, what an owner keeps is lower.

Inverting the record

Invert: instead of why IDEXX Laboratories Inc. is a good business, the question is what would make owning it a mistake, and whether those marks are in the record. Disconfirming tests across 2016–2025.

1 of the 6 tests turned up something to look into; the other 5 came back clean.

  • Look hereAre "one-time" charges a yearly habit?7 of 10 years

    Management took an impairment or write-down in 7 of the last 10 years, $15M in all. Taken across the majority of the record, the "one-time" label is wearing thin — ask whether these are past deals coming due rather than genuinely isolated events. Read it beside the goodwill the company still carries.

And these came back clean
  • Is it less profitable than it was?
  • Did the share count rise anyway?
  • Did debt outgrow the business?
  • Did reported profit become cash?
  • Did receivables and inventory outpace sales?

Each test is read from the filings and is noisy alone; a flag can mark a cyclical trough or a year of heavy investment as easily as a problem. The filing says which.

Peers, Biotechnology

The same industry, side by side on owner economics. Each figure is a through-cycle median, so a peak or trough year can’t distort it; the group median at the foot is the line to read each against.

CompanyRevenueGross marginOp. marginROICOwner earn. margin
ONCBeOne Medicines Ltd.$5.3B86%-124.4%-46%-112%
ELANElanco Animal Health Incorporated$4.7B54%-3.2%-1%4%
IDXXIDEXX Laboratories Inc.$4.3B58%26.2%57%18%
JAZZJazz Pharmaceuticals$4.3B16.8%8%35%
PRGOPerrigo Company plc$4.3B36%3.9%1%6%
ALNYAlnylam$3.7B86%-126.0%-83%-107%
BMRNBioMarin$3.2B78%-1.7%-1%1%
QDELQuidelOrtho$2.7B4.6%24%2%
Group median68%1.1%0%3%
IV

The price

What a price has to assume.

What the price implies

reverse-DCF

Type today's close and see the owner-earnings growth you'd have to believe to justify it, beside what IDEXX Laboratories Inc. has delivered.

IDEXX Laboratories Inc.’s latest year runs above its own through-cycle margin — the reported figure may flatter a peak. So the tool opens on the through-cycle base, Graham’s averaging cutting both ways; clear the toggle below to read the latest year exactly as reported.

$

Through the cycle, IDEXX Laboratories Inc. earns about $758M on its 17.6% median owner-earnings margin. This year’s 24.6% margin runs above that; the reported figure may flatter a peak you'd be paying on. Normalize, below, values the price on that through-cycle figure rather than the latest year. It comes pre-checked here for that reason, the same rule that already normalizes a trough; clear it to price the year as filed.

Base

The assumptions

9.0% = the 4.55% 10-year Treasury (Jul 15, 2026) + 4.45 points of equity premium. The rate you require is yours to set.

Enter a price above to run it.

Implied by the price
Owner-earnings growth · ’21→’25+15%/yr
Owner-earnings growth · ’16→’25+14%/yr
Owner-earnings yield
P/E (3-yr earnings ’23–’25)
P/B
Graham’s price gate

Graham capped the multiple at 15×; Buffett and Munger let that rule go: a wonderful business can deserve 50× if the thesis holds. The gate marks the bargain-hunter's floor.

Against a high-grade bond: Graham’s yardstick bond yield%

Prefilled with the 10-year Treasury (4.55%, as of Jul 15, 2026). Edit it for today’s exact figure, or a AAA corporate yield.

Graham measured a stock against the bond you could own instead, the heart of his margin of safety. Enter a price above to weigh the owner-earnings yield against this bond.

Owner earnings $1.1B on 79M shares outstanding, per the 10-Q cover, as of 2026-04-30; net debt $699M. The base opens on the through-cycle figure (the latest year sits above the record’s own median, and Graham’s averaging cuts both ways); clear Normalize to use the year as filed. Net of stock comp treats option pay as the expense it is. The dials set the multiple a growth belief justifies; the price, and every dollar on this page, is yours.

Cite: Owner Scorecard, "IDEXX Laboratories Inc. (IDXX), the owner's record," https://ownerscorecard.com/c/IDXX, data as of 2026-07-09.

Manual order: ← IDT its page in the Manual IDYA →

Industry order: ← IBRX the Biotechnology chapter IMCR →